Phase II trial of docetaxel–irinotecan combination in advanced esophageal cancer
| Autor: | Burtness, B. *, Gibson, M., Egleston, B., Mehra, R., Thomas, L., Sipples, R., Quintanilla, M., Lacy, J., Watkins, S., Murren, J.R., Forastiere, A.A. |
|---|---|
| Zdroj: | In Annals of Oncology July 2009 20(7):1242-1248 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|